Analysts Set Solventum Co. (NYSE:SOLV) PT at $79.86

Solventum Co. (NYSE:SOLV) has received an average rating of “Hold” from the eleven research firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $79.86.

Several equities research analysts have issued reports on the stock. Piper Sandler boosted their price objective on shares of Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a research report on Friday, February 28th. Bank of America lifted their price target on shares of Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research note on Wednesday, February 26th. Wells Fargo & Company increased their price objective on Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. Morgan Stanley lifted their target price on Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research report on Wednesday, March 5th. Finally, Mizuho increased their price target on Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a research report on Monday, March 3rd.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the stock. New York Life Investment Management LLC raised its holdings in Solventum by 0.7% in the fourth quarter. New York Life Investment Management LLC now owns 18,506 shares of the company’s stock worth $1,223,000 after purchasing an additional 136 shares in the last quarter. Blue Trust Inc. grew its position in shares of Solventum by 2.1% in the 4th quarter. Blue Trust Inc. now owns 7,872 shares of the company’s stock worth $549,000 after buying an additional 161 shares during the last quarter. MML Investors Services LLC raised its stake in shares of Solventum by 3.2% during the 3rd quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock worth $373,000 after acquiring an additional 168 shares in the last quarter. EP Wealth Advisors LLC lifted its position in Solventum by 3.6% during the fourth quarter. EP Wealth Advisors LLC now owns 5,272 shares of the company’s stock valued at $348,000 after acquiring an additional 181 shares during the last quarter. Finally, Avantax Advisory Services Inc. boosted its stake in Solventum by 2.2% in the fourth quarter. Avantax Advisory Services Inc. now owns 8,835 shares of the company’s stock valued at $584,000 after acquiring an additional 192 shares in the last quarter.

Solventum Stock Down 1.0 %

Shares of SOLV opened at $74.78 on Wednesday. The firm has a fifty day moving average price of $75.51 and a 200-day moving average price of $71.83. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The firm has a market capitalization of $12.94 billion and a P/E ratio of 27.19. Solventum has a 12-month low of $47.16 and a 12-month high of $85.92.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.